Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-527.1	759.9	-1,844	-637.3	-	-
Depreciation & Amortization	40.9	165.4	151.6	145.9	-	-
Stock-Based Compensation	15	58	62.3	61.3	-	-
Other Adjustments	592.4	-508.8	2,122	956.2	-	-
Change in Receivables	30.8	19.6	16.2	11.4	-	-
Changes in Inventories	-29.9	68.9	8.5	-46.3	-	-
Changes in Accounts Payable	9.6	-0.1	-40.9	-51.8	-	-
Changes in Income Taxes Payable	-10.2	1.5	24.1	-21.3	-	-
Changes in Other Operating Activities	-13.4	-32.2	-44.7	-43.2	-	-
Operating Cash Flow	510.4	532.2	455.2	374.9	194.4	669.46
Operating Cash Flow Growth	-0.95%	16.92%	21.42%	92.85%	-70.96%	14.44%
Capital Expenditures	-153.2	-157.6	-165.6	-156.7	-112.8	-133.75
Sale of Property, Plant & Equipment	0.2	0.1	0.1	0.2	0.2	0.05
Purchases of Intangible Assets	-	-	-	-	-1.5	-453.44
Purchases of Investments	-742	-669.3	-1,277	-689	-2,060	-851.63
Proceeds from Sale of Investments	827.7	855.6	1,305	863.2	1,066	766.9
Payments for Business Acquisitions	-110.15	-218.5	-23.4	-	-100.7	-125.52
Proceeds from Business Divestments	-	-	-	2.5	1.4	-
Investing Cash Flow	-285.8	-189.7	-160.2	20.2	-1,208	-797.38
Long-Term Debt Issued	-	-	-	-	1,186	-
Long-Term Debt Repaid	-0.5	-0.5	-0.4	-0.5	-0.5	-3.02
Net Long-Term Debt Issued (Repaid)	-0.5	-0.5	-0.4	-0.5	1,186	-3.02
Issuance of Common Stock	14.9	15.8	19.2	18.5	17.6	20.63
Repurchase of Common Stock	-241.4	-295.5	-203.6	-428.7	-215.7	-50
Net Common Stock Issued (Repurchased)	-226.5	-279.7	-184.4	-410.2	-198.1	-29.37
Other Financing Activities	-2.95	-3	-34	-14.9	-14	-23.04
Financing Cash Flow	-229.5	-283.2	-218.8	-425.6	973.6	-55.43
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-9.2	-16.9	9.2	0.4	3	-12.64
Net Cash Flow	-14.1	42.4	85.4	-30.1	-36.6	-195.98
Free Cash Flow	357.2	374.6	289.6	218.2	81.6	535.72
Free Cash Flow Growth	-4.64%	29.35%	32.72%	167.40%	-84.77%	12.45%
FCF Margin	13.79%	14.50%	11.28%	8.17%	2.91%	18.33%
Free Cash Flow Per Share	13.21	13.73	10.26	7.47	2.74	17.73
Levered Free Cash Flow	12.1	805.3	-1,912	-811.2	-2,555	4,117
Unlevered Free Cash Flow	18.85	81.93	144.78	79.84	259.34	256.88

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q